1. Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy
- Author
-
Naohiro Miyashita, Miho Yoshida, Ryo Takemura, Mutsumi Takahata, Shojiro Takahashi, Minoru Kanaya, Emi Yokohata, Tomoyuki Endo, Masahiro Onozawa, Junichi Sugita, Mizuha Kosugi-Kanaya, Katsuya Fujimoto, Takanori Teshima, Takeshi Kondo, Kohei Kasahara, Akio Shigematsu, Daigo Hashimoto, and Shinichi Fujisawa
- Subjects
Chromosome 7 (human) ,030213 general clinical medicine ,Chemotherapy ,Monosomy ,lcsh:RC633-647.5 ,business.industry ,medicine.medical_treatment ,Clone (cell biology) ,Chromosome ,Myeloid leukemia ,Case Report ,lcsh:Diseases of the blood and blood-forming organs ,General Medicine ,medicine.disease ,03 medical and health sciences ,Acute Monoblastic Leukemia ,0302 clinical medicine ,hemic and lymphatic diseases ,030220 oncology & carcinogenesis ,medicine ,Cancer research ,Trisomy ,business - Abstract
We report a case of acute myeloid leukemia (AML) with two cytogenetically unrelated clones. The patient was a 45-year-old male who was diagnosed with acute monoblastic leukemia (AMoL). Initial G-band analysis showed 51,XY,+6,+8,inv(9)(p12q13)c,+11,+13,+19[12]/52,idem,+Y[8], but G-band analysis after induction therapy showed 45,XY,-7,inv(9)(p12q13)c[19]/46,XY,inv(9)(p12q13)c[1]. Retrospective FISH analysis revealed a cryptic monosomy 7 clone in the initial AML sample. The clone with multiple trisomies was eliminated after induction therapy and never recurred, but a clone with monosomy 7 was still detected in myelodysplastic marrow with a normal blast percentage. Both clones were successfully eliminated after related peripheral blood stem cell transplantation, but the patient died of relapsed AML with monosomy 7. We concluded that one clone was de novo AMoL with chromosome 6, 8, 11, 13, and 19 trisomy and that the other was acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) with chromosome 7 monosomy showing different responses to chemotherapy. Simultaneous onset of cytogenetically unrelated hematological malignancies that each have a different disease status is a rare phenomenon but is important to diagnose for a correct understanding of the disease status and for establishing an appropriate treatment strategy.
- Published
- 2016
- Full Text
- View/download PDF